Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.


Inflammatory responses are increasingly implicated in the pathogenesis of neurodegenerative diseases such as in Alzheimer's disease (AD). Interleukin-33 (IL-33), a member of IL-1 family, is constitutively expressed in the central nervous system and thought to be an important mediator of glial cell response to neuropathological lesions. Proinflammatory… (More)
DOI: 10.3233/JAD-132081



Citations per Year

Citation Velocity: 18

Averaging 18 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.
  • Presentations referencing similar topics